Crossmark

What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 2023

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2024.02.001

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Godinho, Daniela http://orcid.org/0009-0007-1863-6276
Freixa, Marta

Froes, Filipe http://orcid.org/0000-0003-4135-6022
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-02-09
More Information

This article is maintained by: Elsevier

Article Title: What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 2023

Journal Title: Pulmonology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2024.02.001

Content Type: simple-article

Copyright: © 2024 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.